Campylobacter pylorn is strongly associated with histologically confirmed gastritis.1 The most convincing evidence for a pathogenic role of C pylori in gastritis comes from trials of treatment." We investigated the role of C pylorn in dyspeptic patients who had gastritis confirmed by histology by performing a prospective trial with colloidal bismuth subcitrate 240 mg twice daily for four weeks. We also report the titres of antibody to C pylorn before and after treatment.
Patients, methods, and results
We studied 66 patients who had dyspepsia without ulcers and took three endoscopic biopsy specimens from both the gastric antrum and duodenal bulb. One specimen was placed in 10% buffered formalin for histology (colonising C pylori were identified by Giemsa stain), and the second was put in 6% urea solution (C pylon' test) . ' The third was placed in 0 5 ml 20% sterile glucose, homogenised, treated with Gram stain, cultured on blood agar with amphotericin (6 ig/ml) and incubated at 37°C for six days. Patients who had a positive C pylon test result from the antrum started receiving treatment the same day as endoscopy. Blood was taken before and after treatment for antibody assessment by ELISA (enzyme linked immunosorbent assay) (sonicated antigen was used and titres determined at optical density 470 nm). Statistical analysis was by two tailed Mann-Whitney U test and matched paired t test after log transformation.
Antral histology showed acute or chronic gastritis, or both, in 32 patients, all of whom showed C pylon on microscopy. The 34 patients who had normal mucosal histology did not have C pyloni and did not receive treatment. At the time of the second endoscopy (one week after finishing treatment) blood was taken, and careful questioning showed that only 19 of 31 patients had complied fully with the four week course of colloidal bismuth subcitrate, despite patients' and doctors' initial consent to participate in the study. Five patients received colloidal bismuth subcitrate for two weeks only, six ranitidine 300 mg daily for four weeks, and one metronidazole 200 mg every eight hours for two weeks. One patient was lost to follow up because he went overseas.
In 13 of 19 patients treated with colloidal bismuth subcitrate histology showed that gastritis had completely resolved and microscopy showed no C pyloni. In six patients there was considerable improvement in the histological samples as well as a decrease in the amount of bacteria. Five patients who took colloidal bismuth subcitrate for only two weeks showed incomplete clearance ofbacteria and gastritis. Histological samples from seven patients given ranitidine or metronidazole showed no change (four patients), mild improvement (one), or worsening (two).
Significantly higher IgG and IgA titres were found in patients who were positive for C pylorn than in patients who were negative for C pylori (p <0-001; MannWhitney U test). IgG and IgA antibody titres were significantly decreased after colloidal bismuth subcitrate treatment (IgG=estimated change of ratios 1-21, confidence interval (CI) 1-10 to 1-32, t=4-31, p<0-001; IgA: estimated change 1 58, Cl 1 33 to 1-86, t=5-57, p<0001) 
